EP3438107
SUBSTITUTED QUINAZOLINE COMPOUND HAVING BLOOD-BRAIN BARRIER PENETRATION CAPABILITY
:
EP einkaleyfi: Þýðing ekki lögð inn:
17.10.2017:
10.6.2020:
17869669.6
:
16.10.2037
:
SUBSTITUTED QUINAZOLINE COMPOUND HAVING BLOOD-BRAIN BARRIER PENETRATION CAPABILITY
17.10.2017
10.6.2020
:
Weishang (Shanghai) Bio-Pharmaceutical Co., Ltd.:
Room E8, 3rd Floor, Building 6 No.4299 Jindu Road Minhang District, Shanghai 201108, CN
:
ZHONG, Wei:
Shanghai 201108, CN
:
201610982608:
8.11.2016:
CN
:
CN2017106616:
17.10.2017
:
C07D 405/14, C07D 401/12, A61K 31/517, A61P 35/00, A61P 25/28